FindTrial
Sign In

Comparison of scan findings to evaluate ovulation rate in patients undergoing ovulation induction treatment with Letrozole and Clomiphene citrate.

Comparison of perifollicular and endometrial vascularity in patients undergoing ovulation induction with Clomiphene citrate and Letrozole

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/02/031447
Enrollment
190
Registered
2021-02-22
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O998- Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Kasturba Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Women undergoing Ovulation induction with Clomiphene citrate or Letrozole

Exclusion criteria

Exclusion criteria: 1. Women undergoing any other form of infertility treatment. 2. Other causes of infertility will be excluded by documentation of a normal uterine cavity, atleast one patent fallopian tube and current partner having a normal semen analysis report

Design outcomes

Primary

MeasureTime frame
effect of clomiphene citrate and letrozole on perifollicular and endometrial vascularityTimepoint: 12 months—

Secondary

MeasureTime frame
Ovulation rate and pregnancy rate in patients treated with clomiphene citrate and letrozoleTimepoint: 12 months—

Countries

India

Contacts

Public ContactDr Nipasa Sarma

Kasturba Hospital

prashanth.adiga@manipal.edu9035036832

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026